@article{ref1,
title="Transdermal Patch Medication Delivery Systems and Pediatric Poisonings, 2002-2006",
journal="Clinical pediatrics",
year="2008",
author="Parekh, Dina and Miller, Michelle A. and Borys, Douglas J. and Patel, Paresh R. and Levsky, Marc E.",
volume="47",
number="7",
pages="659-663",
abstract="Transdermal drug delivery systems are an increasingly popular method of medication delivery containing large quantities of medication and presenting new opportunities for toxicity. To provide a description of exposures to transdermal medications in a pediatric population, we studied exposures in individuals less than 12 years of age. This is a retrospective database study in which the Texas Poison Center Network database from 2002 to 2006 was reviewed. In all, 336 poison control center records of patch exposures over the 5-year period were identified. Of those, 110 cases involved children less than 12 years old. A majority of cases resulted in no significant clinical effects. One death resulted from opioid toxicity. Although a majority of patch exposures in children less than 12 years of age resulted in no significant clinical toxicity, practitioners and the public must be made aware of the available patch-based medications and their potential for toxicity in children. <p>Language: en</p>",
language="en",
issn="0009-9228",
doi="10.1177/0009922808315211",
url="http://dx.doi.org/10.1177/0009922808315211"
}